S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
Log in

Intra-Cellular Therapies News Headlines (NASDAQ:ITCI)

$8.40
+0.18 (+2.19 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$8.04
Now: $8.40
$8.46
50-Day Range
$6.82
MA: $8.56
$10.38
52-Week Range
$6.75
Now: $8.40
$20.08
Volume699,129 shs
Average Volume705,098 shs
Market Capitalization$463.45 million
P/E RatioN/A
Dividend YieldN/A
Beta1.16

Headlines

Intra-Cellular Therapies (NASDAQ ITCI) News Headlines

Source:
DateHeadline
Investors Purchase Large Volume of Call Options on Intra-Cellular Therapies (NASDAQ:ITCI)Investors Purchase Large Volume of Call Options on Intra-Cellular Therapies (NASDAQ:ITCI)
www.americanbankingnews.com - October 4 at 8:49 AM
Intra-Cellular Therapies to Present at the 2019 Cantor Global Healthcare ConferenceIntra-Cellular Therapies to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 30 at 4:14 PM
Zacks: Analysts Anticipate Intra-Cellular Therapies Inc (NASDAQ:ITCI) Will Post Earnings of -$0.91 Per ShareZacks: Analysts Anticipate Intra-Cellular Therapies Inc (NASDAQ:ITCI) Will Post Earnings of -$0.91 Per Share
www.americanbankingnews.com - September 28 at 8:50 PM
Intra-Cellular advances ITI-214 study to 90mg cohortIntra-Cellular advances ITI-214 study to 90mg cohort
seekingalpha.com - September 25 at 8:46 AM
Intra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart FailureIntra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart Failure
finance.yahoo.com - September 25 at 8:46 AM
Intra-Cellular files $350M mixed shelfIntra-Cellular files $350M mixed shelf
seekingalpha.com - September 13 at 4:25 PM
Is the FDA Canceling This Schizophrenia Treatment?Is the FDA Canceling This Schizophrenia Treatment?
247wallst.com - September 11 at 1:54 PM
FDA: No Adcom Meeting For Intra-Cellulars Schizophrenia DrugFDA: No Adcom Meeting For Intra-Cellular's Schizophrenia Drug
finance.yahoo.com - September 11 at 1:54 PM
Intra-Cellular provides lumateperone update; shares up 6% premarketIntra-Cellular provides lumateperone update; shares up 6% premarket
seekingalpha.com - September 10 at 10:44 AM
Intra-Cellular Therapies Provides Lumateperone Regulatory UpdateIntra-Cellular Therapies Provides Lumateperone Regulatory Update
finance.yahoo.com - September 10 at 10:44 AM
How Should Investors React To Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) CEO Pay?How Should Investors React To Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) CEO Pay?
finance.yahoo.com - August 28 at 12:22 PM
Intra-Cellular Therapies: Revisiting The Investment CaseIntra-Cellular Therapies: Revisiting The Investment Case
seekingalpha.com - August 21 at 10:01 PM
Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial ResultsIntra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 7 at 10:09 AM
Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth ConferenceIntra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference
finance.yahoo.com - August 6 at 9:34 AM
Intra-Cellular to submit additional preclinical data for lumateperone NDA; FDA action date extended to December 27; shares up 13% premarketIntra-Cellular to submit additional preclinical data for lumateperone NDA; FDA action date extended to December 27; shares up 13% premarket
seekingalpha.com - August 5 at 11:59 AM
Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDAIntra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA
finance.yahoo.com - August 5 at 11:59 AM
Is Intra-Cellular’s Schizophrenia Treatment in Trouble?Is Intra-Cellular’s Schizophrenia Treatment in Trouble?
247wallst.com - July 24 at 11:10 PM
Intra-Cellular down 31% on cancellation of Ad Com meeting on lumateperoneIntra-Cellular down 31% on cancellation of Ad Com meeting on lumateperone
seekingalpha.com - July 24 at 11:24 AM
Intra-Cellular up 9% premarket on Ad Com update for lumateperoneIntra-Cellular up 9% premarket on Ad Com update for lumateperone
seekingalpha.com - July 24 at 11:24 AM
Intra-Cellular Therapies Provides Update on FDA Advisory Committee Meeting for Lumateperone for the Treatment of SchizophreniaIntra-Cellular Therapies Provides Update on FDA Advisory Committee Meeting for Lumateperone for the Treatment of Schizophrenia
finance.yahoo.com - July 24 at 11:24 AM
Is Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Potentially Underrated?Is Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Potentially Underrated?
finance.yahoo.com - July 23 at 9:39 AM
Intra-Cellular Therapies: Poised To RallyIntra-Cellular Therapies: Poised To Rally
seekingalpha.com - July 19 at 9:38 AM
Intra-Cellular Therapies Falls On Mixed Data, But Main Event With FDA Is Rapidly ApproachingIntra-Cellular Therapies Falls On Mixed Data, But Main Event With FDA Is Rapidly Approaching
seekingalpha.com - July 16 at 7:01 PM
Intra-Cellular - Potential Game ChangerIntra-Cellular - Potential Game Changer
seekingalpha.com - July 15 at 6:39 PM
Intra-Cellular Therapies Candidate Fails in Phase III StudyIntra-Cellular Therapies' Candidate Fails in Phase III Study
finance.yahoo.com - July 9 at 6:29 PM
What Caused The Opening Gap In Intra-Cellular Therapies?What Caused The Opening Gap In Intra-Cellular Therapies?
www.benzinga.com - July 9 at 8:37 AM
Intra-Cellular Therapies stock down 15% after disappointing Phase 3 trial resultsIntra-Cellular Therapies stock down 15% after disappointing Phase 3 trial results
www.marketwatch.com - July 8 at 6:34 PM
Why Deutsche Bank, Intra-Cellular Therapies, and Coherus BioSciences Slumped TodayWhy Deutsche Bank, Intra-Cellular Therapies, and Coherus BioSciences Slumped Today
www.fool.com - July 8 at 5:07 PM
Why Intra-Cellular Therapies Is Tanking TodayWhy Intra-Cellular Therapies Is Tanking Today
www.fool.com - July 8 at 1:46 PM
Oasmia Pharmaceutical and Xenetic Biosciences among healthcare gainers; Intra-Cellular Therapies leads the losersOasmia Pharmaceutical and Xenetic Biosciences among healthcare gainers; Intra-Cellular Therapies leads the losers
seekingalpha.com - July 8 at 11:54 AM
Intra-Cellular drug fails one of two bipolar depression studiesIntra-Cellular drug fails one of two bipolar depression studies
www.nasdaq.com - July 8 at 8:35 AM
Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar DepressionIntra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression
www.nasdaq.com - July 8 at 8:35 AM
Intra-Cellular down 9% premarket on uneven results from lumateperone studiesIntra-Cellular down 9% premarket on uneven results from lumateperone studies
seekingalpha.com - July 8 at 8:35 AM
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts And EarningsThe Week Ahead In Biotech: Conferences, Clinical Trial Readouts And Earnings
finance.yahoo.com - July 7 at 8:31 AM
Intra-Cellular Shares May Double on Bipolar Depression DataIntra-Cellular Shares May Double on Bipolar Depression Data
finance.yahoo.com - July 5 at 6:07 PM
Intra-Cellular Therapies: Caution Ahead Of Major Events This QuarterIntra-Cellular Therapies: Caution Ahead Of Major Events This Quarter
seekingalpha.com - July 3 at 8:42 AM
Intra-Cellular Therapies Appoints Karen Patruno Sheehy, Esq. as Senior Vice President, Chief Compliance OfficerIntra-Cellular Therapies Appoints Karen Patruno Sheehy, Esq. as Senior Vice President, Chief Compliance Officer
finance.yahoo.com - July 2 at 8:37 AM
Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI)Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI)
finance.yahoo.com - June 26 at 6:26 PM
Intra-Cellular Therapies to Present at JMP Securities Life Sciences ConferenceIntra-Cellular Therapies to Present at JMP Securities Life Sciences Conference
feeds.benzinga.com - June 19 at 8:42 AM
Monday 6/17 Insider Buying Report: ITCI, CNRMonday 6/17 Insider Buying Report: ITCI, CNR
www.nasdaq.com - June 18 at 12:44 AM
Implied Volatility Surging for Intra-Cellular (ITCI) Stock OptionsImplied Volatility Surging for Intra-Cellular (ITCI) Stock Options
finance.yahoo.com - June 17 at 7:43 PM
Before You Buy Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Consider Its VolatilityBefore You Buy Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Consider Its Volatility
finance.yahoo.com - June 17 at 7:43 PM
FDA Ad Com July 31 for Intra-Cellulars lumateperone in schizophreniaFDA Ad Com July 31 for Intra-Cellular's lumateperone in schizophrenia
seekingalpha.com - June 13 at 1:21 PM
Intra-Cellular Therapies: Key Catalyst On The HorizonIntra-Cellular Therapies: Key Catalyst On The Horizon
seekingalpha.com - June 13 at 1:21 PM
Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in AdultsIntra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults
finance.yahoo.com - June 13 at 1:21 PM
Intra-Cellular Therapies to Present at Jefferies 2019 Global Healthcare ConferenceIntra-Cellular Therapies to Present at Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 30 at 8:42 AM
2 Biotech Names See Directors Direct Cash to Their Shares2 Biotech Names See Directors Direct Cash to Their Shares
finance.yahoo.com - May 20 at 9:08 AM
Intra-Cellular Therapies to Present at 2019 RBC Capital Markets Global Healthcare ConferenceIntra-Cellular Therapies to Present at 2019 RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - May 16 at 9:51 AM
Intra-Cellular Therapies Announces Presentations on Lumateperone Schizophrenia Program at the American Psychiatric Association (APA) Annual MeetingIntra-Cellular Therapies Announces Presentations on Lumateperone Schizophrenia Program at the American Psychiatric Association (APA) Annual Meeting
finance.yahoo.com - May 15 at 8:46 AM
Edited Transcript of ITCI earnings conference call or presentation 8-May-19 12:30pm GMTEdited Transcript of ITCI earnings conference call or presentation 8-May-19 12:30pm GMT
finance.yahoo.com - May 11 at 5:38 PM
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel